FCGR1A Antikörper (PE)
-
- Target Alle FCGR1A Antikörper anzeigen
- FCGR1A (Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FCGR1A Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS), ELISA, Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- Affinity purified
- Immunogen
- Recombinant Protein
- Isotyp
- IgG1, IgG1 kappa
- Top Product
- Discover our top product FCGR1A Primärantikörper
-
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) (AA 200-292) antibody
FCGR1A Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) (AA 16-145) antibodyFCGR1A Reaktivität: Human FACS, WB, IHC, ELISA, ICC, Neut Wirt: Maus Monoclonal 5F5F12 unconjugated
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) antibodyFCGR1A Reaktivität: Human, Non-Human Primate FACS, WB, ICC, IP, IHC (p), IHC (fro) Wirt: Maus Monoclonal 10-1 unconjugated
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) antibodyFCGR1A Reaktivität: Human, Non-Human Primate FACS, WB, ICC, IP, IHC (p), Func, IHC (fro) Wirt: Maus Monoclonal 10-1 unconjugated
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) antibody (FITC)FCGR1A Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal 10-1 FITC
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) antibody (APC)FCGR1A Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal 10-1 APC
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) (AA 230-280) antibodyFCGR1A Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) (AA 35-235) antibodyFCGR1A Reaktivität: Human WB, ELISA, ICC, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) antibody (Biotin)FCGR1A Reaktivität: Human, Non-Human Primate FACS, WB, ICC, IP, IHC (p), IHC (fro) Wirt: Maus Monoclonal 10-1 Biotin
anti-Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A) (AA 217-245) antibodyFCGR1A Reaktivität: Human FACS, WB, IHC (p) Wirt: Kaninchen Polyclonal RB24072 unconjugated
-
- Applikationshinweise
- Recommended dilution:IF:1:100-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Phosphate-buffered solution, pH 7.4, containing 0.09 % sodium azide and 0.2 % (w/v) BSA
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- FCGR1A (Fc Fragment of IgG, High Affinity Ia, Receptor (CD64) (FCGR1A))
- Andere Bezeichnung
- FCGR1A (FCGR1A Produkte)
- Synonyme
- CD64 antikoerper, CD64A antikoerper, FCRI antikoerper, IGFR1 antikoerper, FcgammaRI antikoerper, Fcgr1 antikoerper, Fcgr1b antikoerper, AI323638 antikoerper, AV092959 antikoerper, IGGHAFC antikoerper, FCGR1A antikoerper, Fc fragment of IgG receptor Ia antikoerper, Fc receptor, IgG, high affinity I antikoerper, FCGR1A antikoerper, Fcgr1a antikoerper, Fcgr1 antikoerper
- Hintergrund
-
Background: CT101 reacts with high affinity receptor for IgG (FcyRI), a 75 kDa type 1 trasmembrane glycoprotein. CD64 is expressed on monocytes and macrophages but not on lymphocytes or resting granulocytes. CD64 play a role in phagocytosis, and antibody dependent cellular cytotoxicity ( ADCC). It also participates in cytokine and superoxide release.1. Ledbetter, J et al. (1981) J Exp Med 153:310-323.2. Haynes, B et al. (1986) Leukocyte Typing II: Human T lymphocytes. New York: Sprimger-Verlag, 3-30.3. Clevers H et al. (1988). Ann Rev Immunol 6: 629-662.4. Barclay, N et al. (1993). The Leucocyte Factsbook. Academic Press. San Diego.
Aliases: N/A
- UniProt
- P12314
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-
